These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17096460)

  • 21. Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study.
    Cookson J; Keck PE; Ketter TA; Macfadden W
    Int Clin Psychopharmacol; 2007 Mar; 22(2):93-100. PubMed ID: 17293709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quetiapine-induced obsessive-compulsive symptoms: a series of five cases.
    Stamouli S; Lykouras L
    J Clin Psychopharmacol; 2006 Aug; 26(4):396-400. PubMed ID: 16855458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quetiapine for sleep in patients with dementia.
    Dolder CR; McKinsey J
    Consult Pharm; 2010 Oct; 25(10):676-9. PubMed ID: 21030358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid dose initiation of quetiapine for the treatment of acute schizophrenia and schizoaffective disorder: a randomised, multicentre, parallel-group, open study.
    Boidi G; Ferro M
    Hum Psychopharmacol; 2007 Jul; 22(5):299-306. PubMed ID: 17487936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Additional evidence of the abuse potential of quetiapine.
    Reeves RR; Brister JC
    South Med J; 2007 Aug; 100(8):834-6. PubMed ID: 17713313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quetiapine dosage in bipolar disorder episodes and mixed states.
    Khazaal Y; Tapparel S; Chatton A; Rothen S; Preisig M; Zullino D
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):727-30. PubMed ID: 17291654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N; Mullen J; Paulsson B; Vågerö M
    J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years.
    Berger GE; Proffitt TM; McConchie M; Kerr M; Markulev C; Yuen HP; O'Donnell C; Lubman D; Polari A; Wood S; Amminger PG; McGorry PD
    J Clin Psychiatry; 2008 Nov; 69(11):1702-14. PubMed ID: 19036233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.
    Vieta E; Calabrese JR; Goikolea JM; Raines S; Macfadden W;
    Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quetiapine for the treatment of bipolar mania in older adults.
    Sajatovic M; Calabrese JR; Mullen J
    Bipolar Disord; 2008 Sep; 10(6):662-71. PubMed ID: 18837860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
    Paleacu D; Barak Y; Mirecky I; Mazeh D
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Administration of once-daily extended release quetiapine in schizophrenic disorders].
    Bartkó G
    Neuropsychopharmacol Hung; 2007 Dec; 9(4):189-95. PubMed ID: 18510263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
    Langosch JM; Drieling T; Biedermann NC; Born C; Sasse J; Bauer H; Walden J; Bauer M; Grunze H
    J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Manic symptoms probably associated with short-term low-dose quetiapine use.
    Erberk-Ozen N
    Adv Ther; 2008 Jan; 25(1):53-8. PubMed ID: 18224291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
    Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR;
    J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Quetiapine in substance use disorders, abuse and dependence possibility: a review].
    Erdoğan S
    Turk Psikiyatri Derg; 2010; 21(2):167-75. PubMed ID: 20514567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quetiapine-induced leucopenia and thrombocytopenia.
    Shankar BR
    Psychosomatics; 2007; 48(6):530-1. PubMed ID: 18071101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quetiapine: efficacy, tolerability and safety in schizophrenia.
    Miodownik C; Lerner V
    Expert Rev Neurother; 2006 Jul; 6(7):983-92. PubMed ID: 16831113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.